C O N T I N U I NG MEDICAL EDUCATION Johns Hopkins University School of Medicine Department of Radiology and Radiological Science presents USE OF CONE BEAM CT DURING CHEMOEMBOLIZATION FOR THE TREATMENT OF LIVER CANCER August 28, 2013 The Johns Hopkins Hospital Interventional Radiology Center Robert I. White Conference Room 1800 Orleans Street, Zayed 7212 Baltimore, Maryland 21287 DESCRIPTION The incidence of liver cancer is rising worldwide and in the U.S. mostly due to the concomitant rise in hepatitis C viral infection. Because liver cancer occurs in the background of cirrhosis, preservation of healthy liver tissue is critically important. Liver cancer arising from the hepatocytes of hepatocellular carcinoma (HCC) has a propensity to stay confined to the liver until late in the disease. Loco‐regional therapies have played a major role in the management of patients with liver cancer. This activity will include review of the most commonly used therapies, transarterial chemoembolization (TACE). Its safety and efficacy have been proven and TACE has been included in all the major guidelines for the treatment of patients with HCC (AASLD, EASL, NCCN). However, technical differences on how to perform TACE persist. We have developed a protocol at Johns Hopkins that would help standardize the procedure. The workshop will provide practical information on how to perform TACE using current sophisticated imaging technology. The hands on program will teach the participants how to use the equipment and become familiar with the capabilities of a newer less evasive technique with cone beam CT imaging. OBJECTIVES After attending this activity, the participant will demonstrate the ability to: • Identify how drug eluting beads DEB‐TACE differs from conventional TACE. •Define the technical aspects of DEB‐TACE. •integrate cone beam CT imaging with DEB‐TACE. •Summarize the benefits of using cone beam CT imaging during DEB‐TACE procedures. •Describe how cone beam CT imaging allows for better visualization and targeting of tumors and assessment of tumor response. TARGET AUDIENCE This activity is intended for interventional radiologists who utilize loco‐ regional therapies to treat liver cancer. ACCREDITATION STATEMENT The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENT The Johns Hopkins University School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACTIVITY DIRECTOR J.F. Geschwind, MD Professor of Radiology and Radiological Science, Surgery and Oncology Interventional Radiology Center Johns Hopkins Medicine Baltimore, Maryland Registration is limited to 12 participants. Pre‐Registration is required. TO REGISTER or FOR FURTHER INFORMATION Register Online (credit card and eCheck) www.HopkinsCME.edu Register by Phone (credit card only) (410) 502‐9635 Register by Fax (866) 510‐7088 Confirmation/Certificates (410) 502‐9635 General Information (410) 955‐2959 E‐mail the Office of CME [email protected] For general information and additional details the direct link for this CME activity is: http://www.hopkinscme.edu/CourseDetail.aspx/80031577 Johns Hopkins University School of Medicine Office of Continuing Medical Education Thomas B. Turner Building Turner 20, 720 Rutland Avenue Baltimore, MD 21205-2195 Follow us on Twitter @ http://twitter.com/HopkinsCME Facebook @ http://www.facebook.com/HopkinsCME

Use of Cone Beam CT During Chemoembolization for the Treatment of Liver Cancer

Download PDF Report

Upload
mdconferencefindercom
View
27
Download
3

Embed Size (px)

Citation preview

Page 1: Use of Cone Beam CT During Chemoembolization for the Treatment of Liver Cancer

CONTINUINGMEDICALEDUCATION

Johns Hopkins University School of Medicine Department of Radiology and Radiological Science presents

USE OF CONE BEAM CT DURING CHEMOEMBOLIZATION FOR THE TREATMENT OF LIVER CANCER

August 28, 2013

The Johns Hopkins Hospital Interventional Radiology Center Robert I. White Conference Room 1800 Orleans Street, Zayed 7212 Baltimore, Maryland 21287

DESCRIPTION The incidence of liver cancer is rising worldwide and in the U.S. mostly due to the concomitant rise in hepatitis C viral infection. Because liver cancer occurs in the background of cirrhosis, preservation of healthy liver tissue is critically important. Liver cancer arising from the hepatocytes of hepatocellular carcinoma (HCC) has a propensity to stay confined to the liver until late in the disease. Loco‐regional therapies have played a major role in the management of patients with liver cancer. This activity will include review of the most commonly used therapies, transarterial chemoembolization (TACE). Its safety and efficacy have been proven and TACE has been included in all the major guidelines for the treatment of patients with HCC (AASLD, EASL, NCCN). However, technical differences on how to perform TACE persist. We have developed a protocol at Johns Hopkins that would help standardize the procedure. The workshop will provide practical information on how to perform TACE using current sophisticated imaging technology. The hands on program will teach the participants how to use the equipment and become familiar with the capabilities of a newer less evasive technique with cone beam CT imaging.

OBJECTIVES After attending this activity, the participant will demonstrate the ability to: • Identify how drug eluting beads DEB‐TACE differs from conventional TACE. •Define the technical aspects of DEB‐TACE. •integrate cone beam CT imaging with DEB‐TACE. •Summarize the benefits of using cone beam CT imaging during DEB‐TACE procedures. •Describe how cone beam CT imaging allows for better visualization and targeting of tumors and assessment of tumor response.

TARGET AUDIENCE This activity is intended for interventional radiologists who utilize loco‐regional therapies to treat liver cancer. ACCREDITATION STATEMENT The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENT The Johns Hopkins University School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACTIVITY DIRECTOR J.F. Geschwind, MD Professor of Radiology and Radiological Science, Surgery and Oncology Interventional Radiology Center Johns Hopkins Medicine Baltimore, Maryland

Registration is limited to 12 participants.

Pre‐Registration is required.

TO REGISTER or FOR FURTHER INFORMATION Register Online (credit card and eCheck) www.HopkinsCME.edu Register by Phone (credit card only) (410) 502‐9635 Register by Fax (866) 510‐7088 Confirmation/Certificates (410) 502‐9635 General Information (410) 955‐2959 E‐mail the Office of CME [email protected] For general information and additional details the direct link for this CME activity is:

http://www.hopkinscme.edu/CourseDetail.aspx/80031577

Johns Hopkins University School of Medicine

Office of Continuing Medical Education

Thomas B. Turner Building

Turner 20, 720 Rutland Avenue

Baltimore, MD 21205-2195